Klinikum Rechts der Isar der TU München

München, Bavaria 81675

0 studies enrolling now · 5 studies all time

What they study most

Alzheimer's Disease, Alzheimer´s Disease, Breast Cancer, COVID-19

Studies at this site

• A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer — Running, not enrolling
• A Study of Baricitinib (LY3009104) in Participants With COVID-19 — Completed
• An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease — Stopped early
• A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease Dementia — Stopped early
• A Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease Dementia — Stopped early